Narval
Designing unconventional, first-in-class antibody drugs using marine biotechnology and AI.
Employees
Enterprise value
$120—180k
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
$30.0k | Angel | ||
| Total Funding | 000k | ||
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads